1. Sanofi-a Ventis Deutschland Gmbh (18 from 1,827 patents)

2. Sanofi-aventis (15 from 389 patents)

3. Aventis Pharma Deutschland, Gmbh (9 from 330 patents)

4. Sanofi (7 from 1,451 patents)

5. Aventis Pharma S.a. (3 from 377 patents)

6. Genzyme Corporation (1 from 787 patents)

1. 11897876 - Isoxazolidines as RIPK1 inhibitors and use thereof

2. 9073975 - Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion

3. 8946212 - Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals

4. 8716317 - Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals

5. 8673917 - 2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors

6. 8580813 - Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals

7. 8415336 - Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals

8. 8344004 - Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals

9. 8329725 - Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals

10. 8211885 - Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals

11. 8153647 - Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics

12. 8143242 - Malonamide derivatives with antithrombotic activity

13. 8088925 - Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors

14. 8039481 - Tetrahydrofuran derivatives for use as inhibitors of matrix metalloproteinases

15. 8003677 - 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as SCD inhibitors